TrademarkDir
SANTHERA
DEAD

Serial Number

77320647

Owner

Santhera Pharmaceuticals Holding AG

Attorney

Patrick J. Concannon

Filing Date

Nov 2, 2007

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

SANTHERA Trademark

Serial Number: 77320647

SANTHERA is a trademark filed by Santhera Pharmaceuticals Holding AG on November 2, 2007. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Santhera Pharmaceuticals Holding AG (9 trademarks)

Hammerstrasse 49

Entity Type: 98

Trademark Details

Filing Date

November 2, 2007

Registration Date

Not Registered

Published for Opposition

September 30, 2008

Goods & Services

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular and metabolic system including diabetes, the respiratory system, musculoskeletal and inflammatory disorders, or for use in dermatology, oncology, hematology, ophthalmology, in transplantation; but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for the treatment of bone, endocrinological, circulatory, hormonal and rheumatic disorders; but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for use in gastro-enterology, for the prevention and treatment of ocular disorders; anti-infectives, anti-bacterials, antivirals, antibiotics, anti-fungals, vaccines, but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for diagnostic purposes, namely, diagnostic preparations for medical purposes; but not for use in the fields of onlcology or rheumatoid arthritis; pharmaceutical preparations for the treatment of central nervous system-related conditions, neurological and muscular diseases, neuro-muscular diseases, muscular dystrophies, ataxias, amyotrophia, atrophy, ophthalmological diseases, muscle wasting, cardiomyopathies, optic nerve degradation, neurological indications, memory loss, Lou Gebrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneurophaties, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; but not for use in the fields of onlcology or rheumatoid arthritis; reagents for medical use; biological preparations for medical purposes but not for use in the fields of onlcology or rheumatoid arthritis; diagnostic agents, preparations and substances for medical purposes

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Dec 9, 2013 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 9, 2013 ABN6
ASSIGNED TO EXAMINER
Sep 9, 2013 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 25, 2013 EXRA
SOU EXTENSION 5 GRANTED
May 24, 2013 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 24, 2013 AITU
SOU EXTENSION 5 FILED
Apr 29, 2013 EXT5
SOU TEAS EXTENSION RECEIVED
Apr 29, 2013 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 31, 2012 EXRA
SOU EXTENSION 4 GRANTED
Oct 30, 2012 EX4G
SOU EXTENSION 4 FILED
Oct 25, 2012 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 25, 2012 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 3, 2012 EXRA
SOU EXTENSION 3 GRANTED
May 2, 2012 EX3G
SOU EXTENSION 3 FILED
Apr 25, 2012 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 25, 2012 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 3, 2011 EXRA
SOU EXTENSION 2 GRANTED
Nov 2, 2011 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 1, 2011 AITU
SOU EXTENSION 2 FILED
Oct 31, 2011 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 31, 2011 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 14, 2011 EXRA
SOU EXTENSION 1 GRANTED
Apr 12, 2011 EX1G
SOU EXTENSION 1 FILED
Apr 12, 2011 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 12, 2011 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 2, 2010 NOAM
PAPER RECEIVED
Sep 17, 2010 MAIL
TTAB RELEASE CASE TO TRADEMARKS
Sep 17, 2010 TMBN
OPPOSITION TERMINATED NO. 999999
Sep 17, 2010 OP.T
OPPOSITION DISMISSED NO. 999999
Sep 17, 2010 OP.D
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 19, 2010 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 19, 2010 REAP
PAPER RECEIVED
May 13, 2010 MAIL
OPPOSITION INSTITUTED NO. 999999
Mar 30, 2009 OP.I
EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 30, 2008 ETOF
PUBLISHED FOR OPPOSITION
Sep 30, 2008 PUBO
NOTICE OF PUBLICATION
Sep 10, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 26, 2008 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 22, 2008 CNSA
AMENDMENT FROM APPLICANT ENTERED
Aug 22, 2008 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2008 CRFA
PAPER RECEIVED
Aug 12, 2008 MAIL
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Feb 16, 2008 CEPE
ASSIGNED TO LIE
Feb 15, 2008 ALIE
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Feb 15, 2008 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Feb 15, 2008 GEAP
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Feb 15, 2008 CPEA
ASSIGNED TO EXAMINER
Feb 14, 2008 DOCK
NEW APPLICATION ENTERED
Nov 7, 2007 NWAP

Related Trademarks

More from this Owner

SANTHERA

SANTHERA

SANTHERA

SANTHERA

SANTHERA

SANTHERA

SANTHERA PHARMACEUTICALS logo

SANTHERA PHARMACEUTICALS

SANTHERA PHARMACEUTICALS logo

SANTHERA PHARMACEUTICALS

SANTHERA PHARMACEUTICALS logo

SANTHERA PHARMACEUTICALS